Cefizox (Page 6 of 6)

HOW SUPPLIED

Cefizox® (ceftizoxime for injection, USP)

NDC 0469­7250­01 Product No. 725001

Equivalent to 500 mg ceftizoxime in 10 mL, single­dose, flip­top vials, individually

packaged

NDC 0469­7251­01 Product No. 725101

Equivalent to 1 gram ceftizoxime in 20 mL, single­dose, flip­top vials, individually

packaged

NDC 0469­7252­01 Product No. 725201

Equivalent to 1 gram ceftizoxime in 100 mL, single­dose, Piggyback, flip­top vials, packaged in tens

NDC 0469­7253­02 Product No. 725302

Equivalent to 2 grams ceftizoxime in 20 mL, single­dose, flip­top vials, individually packaged

NDC 0469­7254­02 Product No. 725402

Equivalent to 2 grams ceftizoxime in 100 mL, single­dose, Piggyback, flip­top vials, packaged in tens

Unreconstituted Cefizox should be protected from excessive light, and stored at controlled room temperature (59º­86ºF) in the original package until used.

Rx only

REFERENCES

  1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically – Fifth Edition. Approved Standard NCCLS Document M7-A5, Vol. 20, No. 2, NCCLS, Wayne, PA, January 2000.
  2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests – Seventh Edition. Approved Standard NCCLS Document M2-A7, Vol. 20, No. 1, NCCLS, Wayne, PA, January 2000.
  3. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria – Fourth Edition. Approved Standard NCCLS Document M11-A4, Vol. 17, No. 22, NCCLS, Wayne, PA, December 1997.
  4. National Committee for Clinical Laboratory Standards. MIC Testing Supplemental Tables. NCCLS Document M100-S10 (M7), NCCLS, Wayne, PA, January 2000.

Product of Japan

Manufactured for:

Fujisawa Healthcare, Inc.

Deerfield, IL 60015-2548

CEFIZOX
ceftizoxime sodium injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0469-7250
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ceftizoxime sodium (ceftizoxime) ceftizoxime 500 mg
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0469-7250-01 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL None
CEFIZOX
ceftizoxime sodium injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0469-7251
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ceftizoxime sodium (ceftizoxime) ceftizoxime 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0469-7251-01 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL None
CEFIZOX
ceftizoxime sodium injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0469-7253
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ceftizoxime sodium (ceftizoxime) ceftizoxime 2 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0469-7253-02 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL None
CEFIZOX
ceftizoxime sodium injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0469-7252
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ceftizoxime sodium (ceftizoxime) ceftizoxime 1 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0469-7252-01 10 VIAL, PIGGYBACK (10 VIAL) in 1 PACKAGE contains a VIAL, PIGGYBACK
1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL, PIGGYBACK This package is contained within the PACKAGE (0469-7252-01)
CEFIZOX
ceftizoxime sodium injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0469-7254
Route of Administration INTRAMUSCULAR, INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ceftizoxime sodium (ceftizoxime) ceftizoxime 2 g
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0469-7254-02 10 VIAL, PIGGYBACK (10 VIAL) in 1 PACKAGE contains a VIAL, PIGGYBACK
1 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1 VIAL) in 1 VIAL, PIGGYBACK This package is contained within the PACKAGE (0469-7254-02)
Labeler — Fujisawa Healthcare, Inc.

Revised: 08/2007 Fujisawa Healthcare, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.